Venus Concept Inc (VERO)
0.726
+0.03 (+3.66%)
USD |
NASDAQ |
May 20, 16:00
0.73
0.00 (0.00%)
After-Hours: 20:00
Venus Concept Profit Margin (Quarterly): -32.64% for March 31, 2022
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -32.64% |
| December 31, 2021 | -13.28% |
| September 30, 2021 | -39.89% |
| June 30, 2021 | 1.46% |
| March 31, 2021 | -40.97% |
| December 31, 2020 | -56.85% |
| September 30, 2020 | -35.02% |
| June 30, 2020 | -56.41% |
| March 31, 2020 | -345.9% |
| December 31, 2019 | -65.29% |
| September 30, 2019 | -33.04% |
| June 30, 2019 | -269.3% |
| Date | Value |
|---|---|
| March 31, 2019 | -137.9% |
| December 31, 2018 | -119.9% |
| September 30, 2018 | -146.7% |
| June 30, 2018 | -114.0% |
| March 31, 2018 | -148.5% |
| December 31, 2017 | -18.15% |
| September 30, 2017 | -157.9% |
| June 30, 2017 | -86.49% |
| March 31, 2017 | -94.52% |
| December 31, 2016 | -95.27% |
| September 30, 2016 | -161.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-345.9%
Minimum
Mar 2020
1.46%
Maximum
Jun 2021
-95.84%
Average
-61.07%
Median
Profit Margin (Quarterly) Benchmarks
| Zymeworks Inc | -3.79K% |
| Aurinia Pharmaceuticals Inc | -174.0% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -4.65K% |
| Liminal Biosciences Inc | -7.14K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.56% |
| Return on Assets | -15.27% |
| Return on Invested Capital | -19.71% |
| Gross Profit Margin (Quarterly) | 67.27% |
| Operating Margin (Quarterly) | -28.16% |
| Return on Net Operating Assets | -23.06% |